Upload
mateus-pucuta
View
14
Download
0
Embed Size (px)
Citation preview
DESIGN AND SYNTHESIS OF ISATIN ANALOGUES
MADC Pucuta1, P Shanika1, RH Hans1*
1Department of Chemistry and Biochemistry, faculty of Science, University of Namibia, Windhoek, Namibia;
*Corresponding author: [email protected]
2. Objectives
1. Introduction
6. The way forward
Approximately 60 % of the world’s population relies almost entirely on plants for
medication.
Natural products have been recognized as an important sources of therapeutically
effective medicines (Farnsworth, Akerele, Bingel, Soejarto, & Guo, 1994). They are
a consistent, valuable source of drug leads and provide greater structural diversity
than compounds obtained through standard combinatorial synthesis.
Natural product research also offers major opportunities for finding novel low
molecular weight lead structures that are potentially active against a wide range of
assay targets (Dias, Urban, & Roessener, 2012).
Isatin (fig. 1) from Isatis tictoria (fig. 1) is the natural product scaffold selected for
this study. It is an indole derivative (1H-indole-2,3-dione) which is a synthetically
versatile substrate and was selected because of its use as starting material for the
synthesis of a large variety of heterocyclic compounds - indoles and quinolines
(Abele, E. & Abele, R., 2003).
Isatin derivatives reportedly display wide range of biological activities which
include antimalarial (Hans, et al, 2010), anticancer (Han, et al, 2014), antiHIV
(Banerjee at al, 2011), antiTB (Sriram at al, 2005).
Isatis tictoria Calanthe Isatin
Figure 1: Sources of isatin and its structure
The objectives of this study are:
Design analogues modelled on isatin
Synthesize isatin analogues
Characterize the advanced intermediates and analogues
3. Methodology
The research project involves the designing and synthesis of triazole-linked isatin
derivatives. The isatin scaffold will be derivatized at:
The nitrogen atom through N-alkylation
The ketonic oxygen by a condensation reaction (Schiff base)
The synthesis of analogues was done in the following order (Scheme 1):
N-alkylation of isatin with propargyl bromide to form an acetylenic isatin
O-alkylation of aldehydes
Aldol condensation reaction of the O-alkylated aldehydes with
acetophenone derivatives to form O-alkylated chalcones
Synthesis of azido chalcone
Click reaction (formation of triazole-linked isatin analogues by clicking the
acetylenic isatin with the azido chalcone).
Characterization of the analogues will be done using physical data (melting
point and retardation factor) and spectroscopy data (Infrared, 1H NMR and 13C NMR).
4. Results and Discussion
7. Acknowledgements
Scheme 1: Synthesis of intermediates and the target molecule
Intermediate/Target
molecule
Chemical Formula
Melting Point (°C)
Rf value
Yield (%)
Novel or
Known
C11H7NO2
153
(158-161) 1
0.79 (EtOAc: Hex 1:1)
37
Known
C9H9BrO2
125
0.27 (EtOAc: Hex 3:7)
27
Known
C9H9BrO2
119
0.77 (EtOAc: Hex)
53
Known
C10H11BrO3
178
0.73 (EtOAc: Hex 3:1)
33
Known
C17H15BrO2
142-144
0.77 (EtOAc: Hex 1:1)
95
Novel
C17H15BrO2
176
0.81 (EtOAc: Hex 1:1)
89
Novel
C18H17BrO3
168
0.73 (EtOAc: Hex 3:1)
61
Novel
C17H15N3O2
145
0.80 (EtOAc: Hex 1:1)
76
Novel
C17H15N3O2
184
0.83 (EtOAc: Hex 1:1)
76
Novel
C18H17N3O3
169
0.74 (EtOAc: Hex 1:1)
96
Novel
Intermediates and analogues have been submitted for NMR analysis (University of
Stellenbosch). After confirmation of the structure analogues (target molecules) will
be submitted for biological testing at UNAM and UCT. Structure Activity
Relationship data delineated from biological results will be used to further improve
the structure of analogues.
University of Namibia, Department of Chemistry and Biochemistry
Prof. Koch, University of Stellenbosch, Faculty of Science, Chemistry Department
Prof Chibale, University of Cape Town, Drug Discovery and Development Centre
(H3-D).
1. Literature value ( http://www.chemspider.com/Chemical-Structure.1468549.html retrieved Oct 23,
2014)
7. References
1. Sriram, D., Yogeeswari, P., & Gopal, G. (2005). Synthesis, anti-HIV and anti-tubercular
activities of lamivudine prodrugs. European Journal of Medicinal Chemistry, 40, 1373-1376.
2. Hans, R. H., Gut, J., Rosenthal, P., & Chibale, K. (2014). Comparison of anti-plasmodial
and falcipain-2 inhibitory activity of β-amino alcohol thiolactone-chalcone and isatin hybrids.
Bioorganic & Medicinal Chemistry Letters, 20, 2234-2237.
3. Han, K., Zhou, Y., Liu, F., Guo, Q., Wang, P., Yang, Y., Teng, Y. (2014). Design, synthesis
and in vitro cytotoxicity evaluation of 5-(2-carboxyethenyl) isatin derivatives as anti-cancer
agents. Bioorganic & Medicinal Chemistry Letters, 24, 756-759.
4. Banerjee, D., Yogeeswari, P., Bhat, P., Thomas, A., Srividya, M., & Sriram, D. (2011). Novel
isatinyl thisemicarbazones derivatives as potential molecule to combat HIV-TB co-infection.
European Journal of Medicinal Chemistry, 46, 106-121.
5. Dias, A. D., Urban, S., & Roessener, U. (2012). An historical overview of natural products
in drug discovery. Metabolites Journal, 2, 303-336.
6. Farnsworth, N. R., Akerele, O., Bingel, A. S., Soejarto, D. D., & Guo, Z. (1994). Medicinal
plants in therapy. Bull World Organ, 63(6), 965-981.
Table 1: Physical data and yields of intermediates
Isatin
Propargyl bromide
Acetylenic isatin
R1
R1= Azido Chalcone
N-alkylation Triazole linker
Chalcone
R= H, ClX= SemicarbazideY= H, OCH3
Thirteen (13) molecules were synthesized and subjected to partial characterization.
Of the 13 compounds 6 compounds are novel and are reported here for the first
time.
Yields obtained for the acetylenic isatin and the O-alkylated aldehydes were lower
than that reported in the literature. This could be due to the presence of moisture in
the reaction mixtures.
5. Discussion